Pietrantonio, F., Lobefaro, R., Antista, M., Miceli, R., Raimondi, A., Lonardi, S., Rimassa, L., Saggio, S., Capone, I., Farina, G., Longarini, R., Mosconi, S., Bianchi, A. S., Tomasello, G., Petrelli, F., Murgioni, S., Perrone, F., Barault, L., Milione, M., Nicolantonio, F. D., Bartolomeo, M. D., & de Braud, F. (n.d.). o-025A randomized, multicenter, phase 2 trial comparing CAPTEM versus FOLFIRI as second-line treatment for MGMT-methylated, RAS-mutated metastatic colorectal cancer patients. Annals of oncology, 30, . http://access.bl.uk/ark:/81055/vdc_100094624836.0x00002f